STACY WACHHOLTZ: Open Payments
NPI 1710605118 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 13 payments from 7 companies in 2025. Trend: 2023 $138 · 2024 $186 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Grifols USA, LLC | 1 | $31 |
| Novo Nordisk Inc | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: ELIQUIS, CAPLYTA, Kerendia, Prolastin-C Liquid, Ozempic, NURTEC ODT, FANAPT, Wegovy.
Industry payments across SD — which companies pay providers there.
